首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1573693

遠端癲癇市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Tele-epilepsy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月26日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球遠程癲癇市場價值為 4.081 億美元，預計 2024 年至 2032 年複合年成長率為 15.9%。

對遠距醫療的認知和接受度的提高，加上政府的支持性政策和有利的報銷框架，將加速遠距癲癇服務的採用。值得注意的是，醫療保險和醫療補助服務中心(CMS) 強調，在過去五年中，包括癲癇在內的慢性疾病的遠距醫療就診次數大幅增加了64%，這凸顯了人們對遠距醫療保健的日益依賴。

隨著遠距醫療解決方案的需求加劇，老年人口數量不斷增加，更容易患癲癇，加上癲癇病例普遍增加，將推動市場成長。世界衛生組織 (WHO) 於 2023 年報告稱，全球約有 5,000 萬人患有癲癇症，其中很大一部分是老年人。這種廣泛的盛行率凸顯了持續監測和管理的必要性，並強調了先進的遠端癲癇技術在確保有效護理方面的關鍵作用。

整個產業分為成分、癲癇類型、年齡層、最終用戶和地區。

該市場按組件細分，包括軟體、服務和硬體。軟體領域佔據市場主導地位，預計在預測期內複合年成長率為 16.2%。在軟體類別中，基於雲端的解決方案和本地解決方案之間存在差異。該軟體的市場主導地位源於其在遠端監測和癲癇管理方面的關鍵功能，為利害關係人提供了資料收集和患者參與的基本工具。這些軟體解決方案有助於即時腦電圖監測、資料分析和遠端會診，以確保持續的患者護理、及時的干涉和客製化的治療計劃，從而提高癲癇管理的有效性。

按癲癇類型細分，遠程癲癇市場包括局部癲癇發作、全身性癲癇發作和組合性癲癇發作類別。 2023 年，由於癲癇發作的高發病率和複雜的管理需求，全身性癲癇細分市場以 59.7% 的佔有率引領市場。鑑於全身性癲癇發作同時影響兩個大腦半球，通常需要持續監測和定期治療調整。

2023 年美國遠程癲癇市場價值為 2.187 億美元，預計到 2032 年底將飆升至 7.955 億美元。美國的優勢在於其成熟的醫療基礎設施和遠距醫療技術的廣泛採用，從遠距診斷到遠距諮詢平台。此外，支持性的政府舉措、優惠的報銷政策和不斷的技術進步進一步鞏固了美國在遠程癲癇市場的主導地位。

產業生態系統分析
產業影響力
- 成長動力
  - 癲癇盛行率上升
  - 遠端監控服務需求不斷成長
  - 遠距醫療服務的技術進步
  - 患者和照護人員的意識不斷提高
- 產業陷阱與挑戰
  - 資料安全和隱私問題
成長潛力分析
未來市場趨勢
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按組成部分，2021 - 2032 年

主要趨勢
軟體
- 基於雲端
- 本地
服務
- 電話諮詢服務
- 遠端監控和篩檢服務
- 遠距教育和培訓
- 其他服務
硬體

第 6 章：市場估計與預測：按癲癇類型，2021 - 2032 年

主要趨勢
局部性癲癇發作
全身性癲癇發作
合併癲癇發作

第 7 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
兒科
成年人

第 8 章：市場估計與預測：按最終用戶，2021 - 2032 年

主要趨勢
醫療保健提供者
- Hospitals and clinics
- Specialized epilepsy centers
- Homecare settings
患者
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Bioserenity SAS
Ceribell, Inc.
CortiCare, Inc.
Epitel, Inc.
Empatica Inc.
MedaSync.
Medtronic plc
NeuroPace, Inc.
Ovation Healthcare
Real Time Tele-Epilepsy Consultants.
ScienceSoft USA Corporation
Seer Medical
Teladoc Health, Inc.
UCB S.A.
Vidyo, Inc.

簡介目錄

Product Code: 11022

The Global Tele-Epilepsy Market was valued at USD 408.1 million in 2023 and is projected to grow at a CAGR of 15.9% from 2024 to 2032. This growth is primarily driven by the rising prevalence of epilepsy and an increasing demand for remote management solutions.

Heightened awareness and acceptance of telehealth, along with supportive government policies and favorable reimbursement frameworks, are set to accelerate the adoption of tele-epilepsy services. Notably, the Centers for Medicare and Medicaid Services (CMS) highlighted a significant 64% surge in telehealth visits for chronic conditions, including epilepsy, over the last five years, underscoring the growing reliance on remote healthcare.

The expanding elderly demographic, more prone to epilepsy, combined with a general uptick in epilepsy cases, is poised to drive market growth as the demand for remote healthcare solutions intensifies. The World Health Organization (WHO) reported in 2023 that around 50 million people globally are affected by epilepsy, with a notable portion being elderly. This widespread prevalence accentuates the necessity for ongoing monitoring and management, underscoring the pivotal role of advanced tele-epilepsy technologies in ensuring effective care.

The overall industry is divided into component, epilepsy type, age group, end-user, and region.

The market, segmented by component, includes software, services, and hardware. Dominating the market, the software segment is projected to grow at a CAGR of 16.2% during the forecast period. Within the software category, there is a distinction between cloud-based and on-premises solutions. The software's market dominance stems from its crucial function in remote monitoring and epilepsy management, equipping stakeholders with essential tools for data collection and patient engagement. These software solutions facilitate real-time EEG monitoring, data analysis, and teleconsultations for ensuring continuous patient care, timely interventions, and tailored treatment plans that bolster the effectiveness of epilepsy management.

Segmented by epilepsy type, the tele-epilepsy market includes focal seizure, generalized seizure, and combined seizure categories. In 2023, the generalized seizure segment led the market with a 59.7% share, driven by the high prevalence and intricate management needs of these seizures. Given that generalized seizures impact both brain hemispheres simultaneously, they often necessitate continuous monitoring and regular treatment adjustments.

U.S. tele-epilepsy market was valued at USD 218.7 million in 2023 and is projected to soar to USD 795.5 million by the end of 2032. This robust growth is attributed to the high prevalence of epilepsy in the U.S., driving demand for advanced management solutions. The U.S. advantage lies in its established healthcare infrastructure and the widespread embrace of telehealth technologies, from remote diagnostics to teleconsultation platforms. Moreover, supportive government initiatives, favorable reimbursement policies, and relentless technological advancements further cement the U.S.'s dominant position in the tele-epilepsy market.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of epilepsy
  - 3.2.1.2 Growing demand for remote monitoring services
  - 3.2.1.3 Technological advancement in telehealth services
  - 3.2.1.4 Rising awareness among patients and caregivers
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Data security and privacy concerns
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Software
- 5.2.1 Cloud-based
- 5.2.2 On-premises
5.3 Services
- 5.3.1 Tele-consultation services
- 5.3.2 Tele-monitoring and screening services
- 5.3.3 Tele-education and training
- 5.3.4 Other services
5.4 Hardware

Chapter 6 Market Estimates and Forecast, By Epilepsy Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Focal seizure
6.3 Generalized seizure
6.4 Combined seizure

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pediatrics
7.3 Adults

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Healthcare providers
- 8.2.1 Hospitals and clinics
- 8.2.2 Specialized epilepsy centers
- 8.2.3 Homecare settings
8.3 Patients
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa